A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Exelixis
Study ID
NCT07428616
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Meningioma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Zanzalintinib — DRUG
    Administered as specified in the treatment arm.

Study Details

The objective of the study is to evaluate efficacy and safety of zanzalintinib in participants with recurrent or progressive meningioma refractory to standard therapies.

Key Dates

First listed
Feb 24, 2026
Start date
May 21, 2026
Status verified
Jul 2026
Primary completion
Feb 29, 2028
Completion
Sep 30, 2029

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Zanzalintinib
    Participants will receive zanzalintinib once daily (QD).

Primary Outcome Measure

Objective Response Rate (ORR) per Response Assessment in Neuro-oncology (RANO) as Assessed by Blinded Independent Central Review (BICR) [ Time Frame: Up to approximately 12 months ]

Central Contacts

  • Exelixis Clinical Trials
    1-888-EXELIXIS (888-393-5494)
    [email protected]
  • Backup or International
    650-837-7400

Locations (12)

FacilityCityStateZIPSite coordinators
University of AlabamaBirminghamAlabama35294-
Mayo Clinic_ArizonaPhoenixArizona85054-
Mayo Clinic_JacksonvilleJacksonvilleFlorida32224-
Baptist Health Miami Cancer InstituteMiamiFlorida33176-
Washington University School of MedicineBay Saint LouisMississippi63110-
Memorial Sloan-Kettering Cancer CenterNew YorkNew York10065-
Mayo Clinic_RochesterRochesterNew York55905-
Duke UniversityDurhamNorth Carolina27710-
UT MD Anderson Cancer CenterHoustonTexas77030-
UT Health San Antonio Mays Cancer CenterSan AntonioTexas78229-
Inova Center for Personalized HealthFairfaxVirginia22031-
UW Carbone Cancer CenterMadisonWisconsin53792-

Find similar trials in Birmingham, AL

By research site
University of Alabama· Birmingham, ALMayo Clinic_Arizona· Phoenix, AZMayo Clinic_Jacksonville· Jacksonville, FLBaptist Health Miami Cancer Institute· Miami, FLWashington University School of Medicine· Bay Saint Louis, MSMemorial Sloan-Kettering Cancer Center· New York, NY

Related Studies